Department of Health
DH Home
You are here:     Advisory bodies > GTAC
About GTAC
Gene therapy
Stem cell therapy
Application procedures
GTAC meetings schedule
Publications and resources
  Contact GTAC  

What is stem cell therapy

What Are Stem Cells?

Researchers have been able to grow certain types of stem cells apparently indefinately in the laboratory. Called a Stem Cell line, these cells have two very important properties. Firstly, they can self-renew or form ‘carbon copies’ of themselves. Secondly, they can be made to differentiate, or convert, into any one of the different types of specialised cell in the human body. Stem Cells which can differentiate into any type of cell in the body are referred to as pluripotent. For example, stem cell lines dervied from the early embryo, or Embryonic Stem Cells, are pluripotent.

Some of our fully-developed tissues also posess stem cells, known as Adult Stem Cells. These stem cells are different from Embryonic Stem Cells because they cannot form any type of cell in the body, that is, they are not pluripotent. Adult Stem Cells can, however, effectively replace a small number of cell types within their tissue of origin.

A very recent breakthrough has shown that normal adult body cells can be ‘reprogrammed’, or switched back, into stem cells that appear to show all the poperties of Embryonic Stem Cells. This is done by ‘re-programming’ the nucleus of adult body cells using genetic modification so that the cells revert back to their earliest developmental stage in the embryo.

What is Stem Cell Therapy?

Perhaps the most successful medical exploitation of stem cells to date has been the use of bone marrow transplantation as therapy for a variety of cancers of the blood and immune systems. Researchers are also hoping to exploit other forms of Adult Stem Cell to treat diseased or damaged tissues of patients.
Given their unrestricted potential to form any kind of cell in the body, scientists have more recently begun to research the possibility of using Embryonic Stem Cell lines to generate replacement cells for a range of diseases where there are unmet medical needs. Because the Embryonic Stem Cell lines can be grown in large amounts, it should be possible to generate sufficient quantities of cells to replace damaged or diseased tissue in patients. This type of approach is known as Stem Cell Therapy or Regenerative Medicine. Induced Pluripotent Stem (iPS) cell lines may also hold the same promise as Embryonic Stem Cells in contributing to the development of novel medical treatments and cell therapy.

GTAC's oversees clinical trials involving: “cells derived from stem cell lines.”

This includes cell therapies derived from:

  • Genetically modified cells
  • Embryonic stem cell lines
  • Multipotent stem cell lines
  • Mesenchymal stem cell lines
  • Foetal stem cell lines
  • Induced Pluripotent Stem (iPS) cell lines

 

Top
copyright: © | last updated: 26 September 2008
 

Search

 
 

    Entire site

Public Health and Clinical Quality

Genetics

Human Genetics Commission

Get Acrobat Reader

Download Adobe Acrobat reader for PDF files

Help with Portable Document Format (PDF)